Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy
Clinical trial NCT06470880 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06470880
- Sponsor
- The Christie NHS Foundation Trust
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2026-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.